SPOTLIGHT: Novartis sues Trimeris for patent infringement

The biopharmaceutical company Trimeris says it's being sued by Novartis for infringing a patent the Swiss drug maker got a month ago. The suit targets Fuzeon, Trimeris' HIV treatment developed in collaboration with Roche and approved in 2003. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.